We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 542 results
  1. L-proline transporter inhibitor (LQFM215) promotes neuroprotection in ischemic stroke

    Background

    L-proline transporter (PROT/SLC6A7) is closely associated with glutamatergic neurotransmission, where L-proline modulates the NMDA receptor...

    Gustavo Almeida Carvalho, Raphaela Almeida Chiareli, ... Mauro Cunha Xavier Pinto in Pharmacological Reports
    Article 31 January 2023
  2. Neuroprotection through G-CSF: recent advances and future viewpoints

    Granulocyte-colony stimulating factor (G-CSF), a member of the cytokine family of hematopoietic growth factors, is 19.6 kDa glycoprotein which is...

    Vikrant Rahi, Sumit Jamwal, Puneet Kumar in Pharmacological Reports
    Article 02 January 2021
  3. GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders

    Movement disorders are neurological conditions characterized by involuntary motor movements, such as dystonia, ataxia, chorea myoclonus, tremors,...

    Divya Soni, Puneet Kumar in Pharmacological Reports
    Article 26 July 2022
  4. Neuroprotective Effects of Cannabidiol Under Cerebral Ischemic Conditions

    Abstract

    The lack of blood flow during cerebral ischemic conditions results in multiple and intricate pathophysiological mechanisms including...

    Erika Meyer, Bianca Andretto de Mattos, ... Rúbia Maria Weffort de Oliveira in Revista Brasileira de Farmacognosia
    Article 01 October 2021
  5. Mechanistic interplay of various mediators involved in mediating the neuroprotective effect of daphnetin

    Daphnetin is a 7, 8 dihydroxy coumarin isolated from different medicinal plants of the Thymelaeaceae family and exhibits copious pharmacological...

    Lovedeep Singh, Amrit Pal Singh, Rajbir Bhatti in Pharmacological Reports
    Article 16 April 2021
  6. Cellular, synaptic, and network effects of chemokines in the central nervous system and their implications to behavior

    Accumulating evidence highlights chemokines as key mediators of the bidirectional crosstalk between neurons and glial cells aimed at preserving brain...

    Joanna Ewa Sowa, Krzysztof Tokarski in Pharmacological Reports
    Article Open access 26 August 2021
  7. Unraveling the mechanistic interplay of mediators orchestrating the neuroprotective potential of harmine

    Neurodegenerative diseases (NDDs) encompass a range of conditions characterized by the specific dysfunction and continual decline of neurons, glial...

    Pankaj Kadyan, Lovedeep Singh in Pharmacological Reports
    Article 17 May 2024
  8. Changes in regulators of lipid metabolism in the brain: a study of animal models of depression and hypothyroidism

    Metabolic disturbances in the brain are assumed to be early changes involved in the pathogenesis of depression, and these alterations may be...

    Katarzyna Głombik, Jan Detka, ... Bogusława Budziszewska in Pharmacological Reports
    Article Open access 11 August 2022
  9. Neuroprotective and Neuroregenerative Properties of Dimeric Dipeptide Mimetics of Individual NGF and BDNF Loops Under Conditions of an Experimental Ischemic Stroke Model

    This article reviews our work devoted to studying the biochemical properties of original dimeric dipeptide mimetics of nerve growth factor (NGF) and...

    P. Yu. Povarnina, T. A. Antipova, ... S. B. Seredenin in Pharmaceutical Chemistry Journal
    Article 10 November 2022
  10. Anti-amnesic and Neuroprotective Potential of Genistein Against Alzheimer’s Disease

    Alzheimer’s disease, the most prevalent neurodegenerative disorder, is characterized by language deficits, impairment of problem-solving ability,...

    Niraj Kumar Singh, Neeraj Verma, ... Jyoti Raghav in Revista Brasileira de Farmacognosia
    Article 27 August 2023
  11. Research progress of propofol in alleviating cerebral ischemia/reperfusion injury

    Ischemic stroke is a leading cause of adult disability and death worldwide. The primary treatment for cerebral ischemia patients is to restore blood...

    Hai**g Zheng, **an **ao, ... **nghua Zhao in Pharmacological Reports
    Article 02 July 2024
  12. Amelioration of Doxorubicin-Induced Cognitive Impairment by Quercetin in a Rat Model of Breast Cancer

    The management of breast cancer by chemotherapeutic agents has significantly increased the survival rates and, at the same time, raised concerns...

    Grandhi Venkata Ramalingayya, Jeena John, ... Nandakumar Krishnadas in Revista Brasileira de Farmacognosia
    Article Open access 02 December 2022
  13. Boswellic Acid Nanoparticles: Promising Strategies for Increasing Therapeutic Effects

    Boswellic acids, the main active compound found in the oleo-gum resin of Boswellia serrata Roxb., Burseraceae, have been used in traditional and...

    Kiana Nakhaei, Sara Bagheri-Hosseini, ... Motahareh Boozari in Revista Brasileira de Farmacognosia
    Article 12 May 2023
  14. Exploring the antidepressant-like potential of the selective I2-imidazoline receptor ligand LSL 60101 in adult male rats

    Background

    While the alteration of I 2 receptors has been associated with neurodegenerative and psychiatric disorders, among other brain dysfunctions,...

    Elena Hernández-Hernández, Jesús A. García-Sevilla, M. Julia García-Fuster in Pharmacological Reports
    Article 03 August 2020
  15. Vitamin K: a Potential Neuroprotective Agent

    Neurodegeneration, a progressive disease due to the arrested development of atrophy and regression of neuron function, is the most common disorder...

    Kaberi Chatterjee, Papiya Mitra Mazumder, Sugato Banerjee in Revista Brasileira de Farmacognosia
    Article 27 March 2023
  16. Neuroprotective effect of apelin-13 and other apelin forms—a review

    Neurodegenerative diseases, which occur when neurons begin to deteriorate, affect millions of people worldwide. These age-related disorders are...

    Katarzyna Kamińska, Hubert Borzuta, ... Agnieszka Cudnoch-Jędrzejewska in Pharmacological Reports
    Article 03 April 2024
  17. Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression

    Depression is a highly prevalent mood disorder and one of the major health concerns in modern society. Moreover, it is characterized by a high...

    Jan Detka, Katarzyna Głombik in Pharmacological Reports
    Article Open access 18 May 2021
  18. Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management

    The gut microbiota that exists in the human gastrointestinal tract is incredibly important for the maintenance of general health as it contributes to...

    Yueyue Guan, Guohua Tang, ... Jun Tang in Archives of Pharmacal Research
    Article Open access 15 January 2024
  19. DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson’s disease: a mutual relationship

    Parkinson’s disease (PD) usually occurs due to the degeneration of dopaminergic neurons in the substantia nigra (SN). Management of PD is restricted...

    Mohammed Alrouji, Hayder M. Al-kuraishy, ... Gaber El-Saber Batiha in Pharmacological Reports
    Article 03 June 2023
  20. Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases

    Neurodegenerative diseases (NDDs) pose a significant issue in healthcare, needing a thorough knowledge of their complex molecular mechanisms. A...

    Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh in Pharmacological Reports
    Article 25 June 2024
Did you find what you were looking for? Share feedback.